HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cabrita, G. Articles by Kemp, G. Search for Related Content PubMed PubMed Citation Articles by Cabrita, G. Articles by Kemp, G. Social Bookmarking                      What's this?

Volume 272, Number 9, Issue of February 28, 1997 pp. 5635-5639
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Activation of the Adenovirus Protease Requires Sequence Elements from Both Ends of the Activating Peptide

(Received for publication, August 5, 1996, and in revised form, November 5, 1996)

From the Division of Cell and Molecular Biology, University of St. Andrews, Irvine Building, North Street, St. Andrews KY16 9AL, Scotland

The adenovirus protease requires activation by an 11-residue peptide, GVQSLKRRRCF, to achieve maximum proteolytic activity. Derived from the C terminus of the viral protein pVI, the activating peptide (pVI-CT) forms a disulfide bond with cysteine 104 of the protease and causes a conformational change that accompanies the development of proteolytic activity. Results presented here show that the interaction of pVI-CT with the protease is dependent not only on the cysteine 10 but also on glycine 1 and valine 2. Removal of these residues, acetylation of the N-terminal glycine, or mutation of the valine to alanine or threonine significantly reduces or abolishes activation. Peptides lacking Gly-1 and Val-2 still form a disulfide bond with the protease but do not cause a conformational change in the protease also they are not effective inhibitors of activation as the interaction is readily reversed by full-length pVI-CT. These results suggest that pVI-CT causes activation by binding to two distinct regions of the protease and in doing so stabilizes the catalytic site. The reversible nature of the activation, suggested by the results presented here, may well reflect an in vivo regulatory mechanism.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. S. Honkavuori, B. D. Pollard, M. S. Rodriguez, R. T. Hay, and G. D. Kemp Dual role of the adenovirus pVI C terminus as a nuclear localization signal and activator of the viral protease J. Gen. Virol., November 1, 2004; 85(11): 3367 - 3376. [Abstract] [Full Text] [PDF]

				M. T. Brown, K. M. McBride, M. L. Baniecki, N. C. Reich, G. Marriott, and W. F. Mangel Actin Can Act as a Cofactor for a Viral Proteinase in the Cleavage of the Cytoskeleton J. Biol. Chem., November 22, 2002; 277(48): 46298 - 46303. [Abstract] [Full Text] [PDF]